Kliniske studier for KOLS i Nevada
8 studier for KOLS søker deltakere på steder i Nevada.
Byer i Nevada
Offisiell studietekst (engelsk)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Las Vegas
- Research Site, Las Vegas
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Excel Clinical Research - Las Vegas- Site Number : 8400070, Las Vegas
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Henderson Clinical Trials- Site Number : 8400026, Henderson
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07190209A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Las Vegas
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Henderson Clinical Trials, Henderson
RekruttererFase 2/3
Alder 35 til 80 · Alle kjønn · Oppdatert 31. aug. 2026 · NCT07363694eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Henderson
- GSK Investigational Site, Las Vegas
- GSK Investigational Site, Reno
RekruttererFase 3
Alder 40 til 75 · Alle kjønn · Oppdatert 28. jul. 2026 · NCT07177339Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Las Vegas
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 9. apr. 2026 · NCT06961214Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Renown Regional Medical Center, Reno
RekruttererObservasjonsstudie
Alder 50 og eldre · Alle kjønn · Oppdatert 5. aug. 2025 · NCT06122077Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.